US Homebuilders D.R. Horton and Lennar Accused of Widespread Construction Defects

2025-09-13
US Homebuilders D.R. Horton and Lennar Accused of Widespread Construction Defects

America's two largest homebuilders, D.R. Horton and Lennar, are facing accusations of widespread construction defects in their new homes, including substandard materials and blatant building code violations, rendering homes unsafe and uninhabitable. Homeowners describe a frustrating warranty process riddled with delays and denials, often leading to expensive repairs out-of-pocket. The investigation reveals a corporate playbook designed to shift costs to buyers through high-pressure sales tactics, one-sided contracts, and legal loopholes to avoid liability. While some homeowners pursue legal action, many find themselves trapped in a system that heavily favors the builders.

Read more

Schrödinger: The Biotech Firm Trying to Crack the AI Drug Discovery Code

2025-01-25
Schrödinger: The Biotech Firm Trying to Crack the AI Drug Discovery Code

Schrödinger, a biotech company using quantum mechanics to design new medicines and materials, boasts all top 20 pharmaceutical companies as clients. Despite this, five years post-IPO, its stock price languishes near all-time lows. This article explores Schrödinger's unique business model—part biotech, part software—and its struggles with valuation. A pivotal dinner between Nvidia's Jensen Huang and Schrödinger's CEO highlighted a crucial turning point: embracing AI more fully. While initially hesitant, Schrödinger now leverages AI's power, particularly AlphaFold's protein structure predictions, and is preparing for crucial clinical data releases in 2025. The company's future hinges on successfully navigating the complex interplay of software sales, biotech pipeline development, and clear investor communication.

Read more